Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2026-02-01 @ 7:18 PM
Study NCT ID:
NCT02707861
Status:
COMPLETED
Last Update Posted:
2021-03-11
First Post:
2016-03-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Sponsor:
TaiMed Biologics Inc.
Organization: